Share Price:

APNASPENAspen Pharmacare Hldgs21701-219 (-1.00%)
Our Response to Covid
Country Sites

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform to be released on 4 March 2024.

Regional Overviews

Aspen in Americas

Mexico and Brazil in the Latin America region continue to perform and lead in terms of revenue contribution and growth. The region actively promotes regional and global brands through hospital, prescription and over‑the-counter (“OTC“) sales. Brazil also has a manufacturing site which specialises in finished dose form (“FDF“).

Key Countries

Brazil
Canada
Chile
Colombia
Ecuador
Mexico
USA

Overview

Learn More
Brand Therapeutic category

Diprivan

General anaesthetic

Meticorten

Corticosteroid

Milk of Magnesia

Antacids/antiflatulants

Perfalgen

Analgesic injectable

Xylocaine

Regional anaesthetic
5
Products
Launched

(2022: 20)

Product
Recalls

(2022: 1)

5 %
Average Staff
Turnover

(2022: 22)

Work-related
Facilities

(2022: Nil)

135
Sales
Representatives

(2022: 235)

250
Permanent
Employees

(June 2022: 714)

Revenue 2023
R’million		 2022 (CER)
R’million		 Change
%

Commercial Pharmaceuticals

Regional Brands

3 452

3 373

2

Sterile Focus Brands

1 627

1 657

(2)

Manufacturing

FDF - Other

19

-

>100
Total

5 098

5 030

1

Note: Commercial Pharmaceuticals revenue by customer geography and manufacturing revenue by place of manufacture.

Contribution to Group revenue (%)
  • Rest of Group 88
  • Americas 12
Revenue by segment (%)
  • Regional Brands 68
  • Sterile Focus Brands 32

Our Purpose

Find out more
To improve the health and quality of life of patients.

Our Vision

Find out more
To deliver value to all our stakeholders as a responsible corporate citizen that provides high-quality, affordable medicines globally.

Our Values

Find out more
Define the foundation on which Aspen has been built. These are the values we share as we work together toward achieving the vision of the Group.
aspen-holdings-logo-white-img

Aspen Holdings
www.aspenpharma.com
Hotline (South Africa)
0800 122 912

Medical Careline (South Africa) 0800 118 088

Facebook-f Twitter-square Instagram Linkedin

About Aspen

We Care

Careers

Contact Us

ASPEN PHARMACARE HOLDINGS LTD:
Switchboard: +27 31 580-8600

Aspen Place
9 Rydall Vale Park
Douglas Saunders Drive
La Lucia Ridge
South Africa

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.